GlassScriptPhysician profile
Stacey C Reid
NPI 1679778419
$3,434.53
in general payments reported to CMS, 2019-2025
33 companies · $533 in 2025
The $533 reported for 2025 was more than what 96% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $771 · 2022: $632 · 2023: $799 · 2024: $699 · 2025: $533.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,031.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,030.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $462.34 | 2021-2024 | Veozah, Myrbetriq |
| Abbvie INC. | $405.19 | 2021-2025 | |
| Amgen INC. | $386.83 | 2021-2025 | Evenity, Prolia, Prolia |
| Shield Therapeutics INC | $374.64 | 2023-2025 | Accrufer |
| Pfizer INC. | $332.14 | 2021-2024 | |
| Evofem Biosciences, INC. | $216.38 | 2021-2023 | Phexxi |
| Bayer Healthcare Pharmaceuticals INC. | $208.42 | 2021-2025 | |
| Organon LLC | $116.01 | 2021-2023 | Nexplanon |
| Mayne Pharma Commercial LLC | $99.07 | 2024-2025 | |
| Pacira Pharmaceuticals Incorporated | $70.98 | 2022-2025 | Exparel |
| Novo Nordisk INC | $69.99 | 2021-2025 | Wegovy |
| Avion Pharmaceuticals | $67.95 | 2021-2023 | Balcoltra |
| Baxter Healthcare | $67.66 | 2022-2023 | Perclot |
| Myriad Women'S Health, INC. | $59.47 | 2023 | Myrisk |
| Millicent US INC | $45.00 | 2024-2025 | Intrarosa, Femring, Femlyv |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $44.86 | 2021-2022 | |
| Lilly USA, LLC | $43.66 | 2024-2025 | Zepbound |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.53 | 2022-2023 | Trulance |
| Biohaven Pharmaceuticals, INC. | $34.05 | 2021 | |
| Exact Sciences Corporation | $33.23 | 2023-2024 | Cologuard Collection Kit |
| Aspira Women'S Health INC | $28.71 | 2024 | Ova1 |
| Glaxosmithkline, LLC. | $27.20 | 2021 | |
| Daiichi Sankyo INC. | $24.88 | 2022 | |
| Radius Health, INC. | $24.75 | 2024 | Tymlos |
| Hologic Sales and Service, LLC | $23.33 | 2022 | |
| Axonics, INC. | $21.82 | 2023 | Axonics |
| Davol INC. | $19.84 | 2024 | Arista Ah Flexitip |
| Sage Therapeutics, LLC | $17.33 | 2024 | |
| Channel Medsystems, INC. | $16.56 | 2024 | |
| Urovant Sciences INC | $15.38 | 2022 | |
| Merck Sharp & Dohme LLC | $15.15 | 2021 | |
| Agile Therapeutics, INC. | $13.62 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.56 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacey Reid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.